*The 3-year first-time residency attainment rate is the weighted average of the 2022-23, through 2024-25 academic years. For each year, the rate is the percent of students attaining a residency out of all graduates or expected graduates in the year who were active applicants in the NRMP match in that year or who attained a residency outside the NRMP match in that year. The 1-year first-time residency attainment rate is 95% for 2024-2025 graduates.
Peter Chovanec, PhD
Professor, Molecular and Cell Biology
Peter Chovanec, PhD, is a Professor of Molecular Cell Biology at the AUC School of Medicine’s UK Track program. Dr. Chovanec is also a faculty member at the University of Lancashire in Preston, UK, where the program is delivered. Dr. Chovanec holds an MSc and PhD in biochemistry from the Slovak University of Technology in Bratislava, Slovakia. From 2002 to 2011, he conducted postdoctoral research at academic institutions including Stockholm University in Sweden, the University of Manchester in the United Kingdom, and Duquesne University in the United States. His research, which spans multiple disciplines and employs state of the art technologies, has been widely published in international journals and textbooks. Dr. Chovanec has served as full-time faculty at several international medical schools in the Caribbean, including the University of St. Eustatius School of Medicine in St. Eustatius, Saba University School of Medicine in Saba, and the Medical University of the Americas in Nevis, West Indies. He has been part of the AUC School of Medicine since 2019 and was promoted to Professor in 2024. In recent years, Dr. Chovanec has also been actively involved in medical pedagogy research, with a focus on post-pandemic educational transitions, curriculum development, and the academic experiences of international medical students.